共 377 条
[1]
Araujo J(2010)Dasatinib: a potent src inhibitor in clinical development for the treatment of solid tumors Cancer Treat Rev 36 492-500
[2]
Logothetis C(2008)Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse Clin Cancer Res 14 3306-3311
[3]
Bidard FC(2005)A pooled analysis of bone marrow micrometastasis in breast cancer N Engl J Med 353 793-802
[4]
Vincent-Salomon A(1997)Skeletal complications of malignancy Cancer 80 1588-1594
[5]
Gomme S(2011)Breast-cancer adjuvant therapy with zoledronic acid N Engl J Med 365 1396-1405
[6]
Nos C(1998)Clinical course and prognostic factors following bone recurrence from breast cancer Br J Cancer 77 336-340
[7]
de Rycke Y(2000)Identifying breast cancer patients at high risk for bone metastases J Clin Oncol 18 3925-3935
[8]
Thiery JP(2001)Prognostic factors for skeletal relapse in breast cancer Cancer Treat Rev 27 153-157
[9]
Sigal-Zafrani B(2010)Efficacy of zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: 36-month results of the ZO-FAST Study Ann Oncol 21 2188-2194
[10]
Mignot L(2002)Molecular prognostic factors for breast cancer metastasis and survival Semin Radiat Oncol 12 319-328